Today, BIO sent a letter to Reps. Boehner and Pelosi in support of the 21st Century Cures Act.
In the letter, we applaud Chairman Upton, Ranking Member Pallone and Congresswoman DeGette’s efforts on H.R. 6., which takes important steps toward placing patients at the center of the drug development process.
We also expressed support for precision medicine through genomics and regulatory science to help better understand the molecular basis of disease and develop precision therapies tailored to each patient.
Furthermore, we support enhancing the FDA’s scientific capacity by improving access to adequate funding, enhancing the ability to recruit and retain world-class scientific and technical experts, and expanding management processes and human resource functions to meet the complexities of 21st Century scientific discovery.
In the letter, we noted the important inclusion in this legislation of provisions to ensure privately-paid user fees to FDA are protected from the effects of any future sequestration.
The full letter can be found here.